EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Quantitative and Qualitative Parameters of DCE-MRI Predict CDKN2A/B Homozygous Deletion in Gliomas

Huiquan Yang, Zhengyang Zhu, Cong Long, Fengnan Niu, Jianan Zhou, Sixuan Chen, Meiping Ye, Siqi Peng, Xue Zhang, Ying Chen, Liangpeng Wei, Haoyao Wang und 4 weitere

Academic Radiology · 2024-08 · 31 (8) · 3355-3365

DOI: 10.1016/j.acra.2024.02.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academic Radiology, 2024-08. Verfasst von Huiquan Yang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Glioma, Magnetic Resonance Imaging, Brain Neoplasms, Cyclin-Dependent Kinase Inhibitor p16. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RATIONALE AND OBJECTIVES: Homozygous deletion (HD) of CDKN2A/B holds important prognostic value in gliomas. This study aimed to explore the predictive potential of conventional MRI characteristics combined with dynamic contrast-enhanced MRI parameters in predicting CDKN2A/B HD status in gliomas. MATERIALS AND METHODS: Preoperative MRI data of 105 patients (69 without CDKN2A/B HD, and 36 with CDKN2A/B homozygous deletion) with gliomas were retrospectively collected. Conventional MRI features and dynamic contrast-enhanced-MRI qualitative parameter time-intensity curve type, quantitative parameters Ktrans, Kep, Ve, Vp, and iAUC were obtained. Logistic regression models for prediction of CDKN2A/B HD status were constructed in all types of gliomas and both subtypes of IDH-mutant and IDH-wild gliomas. RESULTS: Multivariate analysis for all patients demonstrated that age (OR=1.103, p = 0.002) and Ktrans (OR=1.051, p < 0.001) independently predicted CDKN2A/B HD. In IDH-mutant subgroup, multivariate analysis results indicated that Ktrans (OR=1.098, p = 0.031) emerged as autonomous predictors of CDKN2A/B HD. In IDH-wild subgroup, age (OR=1.111, p = 0.002) and Ktrans (OR=1.032, p = 0.001) were independent predictors of CDKN2A/B HD according to the multivariate analysis. The areas under the receiver operating characteristic curve of the corresponding models were 0.90, 0.95 and 0.84, respectively. CONCLUSION: Ktrans can serve as valuable predictive parameters for identifying CDKN2A/B HD status in all types of gliomas and both subtypes of IDH-mutant and IDH-wild gliomas. These findings provide a foundation for precise preoperative non-invasive diagnosis and personalized treatment approaches for glioma patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaMagnetic Resonance ImagingBrain NeoplasmsCyclin-Dependent Kinase Inhibitor p16Contrast MediaHumansFemaleMaleMiddle AgedAdultRetrospective StudiesCyclin-Dependent Kinase Inhibitor p15HomozygoteGene DeletionAgedPredictive Value of Tests

Stichwörter der Autor:innen

CDKN2A/B homozygous deletionDCE-MRIGliomasPredict

Substanzen

Cyclin-Dependent Kinase Inhibitor p16Contrast MediaCyclin-Dependent Kinase Inhibitor p15CDKN2A protein, humanCDKN2B protein, human

Autor:innen und Institutionen

  • Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Department of Pathology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • School of Life Science and Technology, Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing, China.
  • Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Electronic address: zhangxin@njglyy.com.
  • Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China; Medical Imaging Center, Affiliated Drum Tower Hospital, Medical School of Nanjing Universi…

Förderung

  • China Postdoctoral Science Foundation

Zitieren

APA

Yang, H., Zhu, Z., Long, C., Niu, F., Zhou, J., Chen, S., Ye, M., Peng, S., Zhang, X., Chen, Y., Wei, L., Wang, H., Liu, D., Yao, M., Zhang, X., & Zhang, B. (2024). Quantitative and Qualitative Parameters of DCE-MRI Predict CDKN2A/B Homozygous Deletion in Gliomas. Academic Radiology, 31(8), 3355-3365. https://doi.org/10.1016/j.acra.2024.02.017

Vancouver

Yang H, Zhu Z, Long C, Niu F, Zhou J, Chen S, et al. Quantitative and Qualitative Parameters of DCE-MRI Predict CDKN2A/B Homozygous Deletion in Gliomas. Academic Radiology. 2024;31(8):3355-3365. doi:10.1016/j.acra.2024.02.017

BibTeX
@article{Yang2024,
  author = {Yang, Huiquan and Zhu, Zhengyang and Long, Cong and Niu, Fengnan and Zhou, Jianan and Chen, Sixuan and Ye, Meiping and Peng, Siqi and Zhang, Xue and Chen, Ying and Wei, Liangpeng and Wang, Haoyao and Liu, Dongming and Yao, Mei and Zhang, Xin and Zhang, Bing},
  title = {Quantitative and Qualitative Parameters of DCE-MRI Predict CDKN2A/B Homozygous Deletion in Gliomas},
  journal = {Academic Radiology},
  year = {2024},
  volume = {31},
  number = {8},
  pages = {3355--3365},
  doi = {10.1016/j.acra.2024.02.017}
}
Kostenlos starten →